Eurofins · 1 day ago
Cell-Based Assay Scientist
Eurofins Scientific is an international life sciences company providing a range of analytical testing services. The Cell-Based Assay Scientist will perform routine cell-based assays, including ELISA and cell culture methods, while ensuring compliance with GMP standards and collaborating with cross-functional teams.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Performing routine cell-based assays, including ELISA and cell culture-based methods, to support product testing
Executing work in a GMP or GMP-like environment, following established protocols and documentation standards
Supporting GMP testing for drug products, with attention to accuracy and compliance
Practicing and maintaining environmental containment procedures
Ensuring proper documentation and reporting aligned with good documentation practices
Collaborating with cross-functional teams to support quality control and product development timelines
Qualification
Required
Bachelor's or Master's degree in a relevant life science discipline (e.g., Biotechnology, Biology, Biochemistry, Molecular Biology, or related field)
1-3 years of relevant industrial experience
Hands-on experience with cell culture and ELISA
Familiarity with working in a regulated/GMP-like lab environment
Strong attention to detail and adherence to standard operating procedures
Candidates within a commutable distance of Chesterfield, MO are encouraged to apply
Authorization to work in the United States indefinitely without restriction or sponsorship
Preferred
Familiarity with OEB-5 compound handling and environmental containment practices
Familiarity with method qualification or validation under GMP
Previous work experience in a QC or regulated lab setting
Benefits
Comprehensive medical coverage, with dental and vision options
Life and disability insurance
Paid holidays and vacation.
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase